Form4insider filings, from the source

SEC Form 4 · accession 0000904454-17-000580

Clovis Oncology, Inc. · CLVS

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owner
Period of report
Aug 16, 2017
Accepted (ET)
Aug 18, 2017 · 4:14 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001466301

Table I — non-derivative securities

SecurityDateCodeSharesPriceA/DOwned afterD/INature of ownership
Common StockF1,F2Aug 16, 2017J92,518$0.00D0IBy One Palmer Square Associates VII, LLC
Common StockF1Aug 16, 2017J4,835$0.00A7,020D
Common StockF1,F3Aug 16, 2017J6,477$0.00A9,404IBy Susan W. and James C. Blair Family L.P.
Common StockF2holding———1,000,000IBy Domain Partners VII, L.P.
Common StockF2holding———17,056IBy DP VII Associates, L.P.
Common StockF2holding———32,760IBy Domain Associates, LLC

Table II — derivative securities

No Table II lines on this filing.

Explanation of responses